Breaking News Instant updates and real-time market news.

AMPH

Amphastar

$16.27

0.17 (1.06%)

, AVDL

Avadel Pharmaceuticals

$9.45

-0.16 (-1.66%)

18:59
09/25/17
09/25
18:59
09/25/17
18:59

Amphastar announces FDA approval of Neostigmine Methylsulfate Injection, USP

Amphastar (AMPH) announced that the U.S. FDA granted approval of its abbreviated new drug application for Neostigmine Methylsulfate Injection, USP, 1mg/mL, 10mL, and 0.5mg/mL, 10mL vial. Amphastar's newly approved product was determined by the FDA to be therapeutically equivalent to Bloxiverz sold in the United States by Avadel (AVDL), with the same active ingredients, route of administration, strength and dosage form. According to IMS Health data, U.S. brand and generic sales of Neostigmine Methylsulfate Injection, USP, 1mg/mL, 10mL, and 0.5mg/mL, 10 mL were approximately $185M for the 12 months ended June 30, 2017. Amphastar anticipates launching its product in the fourth quarter of 2017.

AMPH

Amphastar

$16.27

0.17 (1.06%)

AVDL

Avadel Pharmaceuticals

$9.45

-0.16 (-1.66%)

  • 25

    Sep

  • 26

    Sep

  • 04

    Oct

  • 05

    Oct

AMPH Amphastar
$16.27

0.17 (1.06%)

07/21/17
WELS
07/21/17
NO CHANGE
WELS
Outperform
Amphastar 'David-vs-Goliath' win over Momenta a major victory, says Wells Fargo
Wells Fargo analyst David Maris said a jury's ruling that a Momenta (MNTA) patent was invalid and unenforceable is a very positive outcome for Amphastar (AMPH) in its "David-vs-Goliath-type" case. While he expects Momenta and partner Novartis' (NVS) Sandoz to appeal, Maris thinks this ruling puts Amphastar in a good position for any future potential settlement talks. Maris does not think investors should "count on any windfall" for Amphastar, but he does think, if approved, this could be an over $50M opportunity and keeps an Outperform rating on the stock, which is up 2% to $18.32 in afternoon trading.
03/14/17
03/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Corning (GLW) downgraded to Neutral from Buy at Goldman with analyst Doug Clark citing valuation with the stock up 33% since his upgrade back in April of 2016. The analyst keeps a $29 price target for the shares. 2. Amphastar (AMPH) downgraded to Outperform from Strong Buy at Raymond James with analyst Elliot Wilbur saying he sees an increased near-term risk profile following indications from FDA that Amphastar may have to withdraw its epinephrine product. 3. Abbott (ABT) downgraded to Market Perform from Outperform at BMO Capital. 4. GGP (GGP) downgraded to Neutral from Buy at UBS with analyst Jeremy Metz saying he does not see headwinds in the sector easing in the short term and cut his price target for GGP shares to $25 from $28. 5. Harmonic (HLIT) downgraded to Hold from Buy at Drexel Hamilton. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/17
RAJA
03/14/17
DOWNGRADE
Target $18
RAJA
Outperform
Amphastar downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Elliot Wilbur downgraded Amphastar Pharmaceuticals to Outperform and lowered his price target for the shares to $18 from $21. The analyst sees an increased near-term risk profile following indications from FDA that Amphastar may have to withdraw its epinephrine product.
02/21/17
WELS
02/21/17
NO CHANGE
WELS
Outperform
Wells calls Amphastar CRL for naloxone spray 'disappointing and surprising'
Wells Fargo analyst David Maris said the fact that the FDA issued a Complete Response Letter, or CRL, to Amphastar on its nasal naloxone product was both "disappointing and surprising" given that the company currently markets the leading injectable generic naloxone. However, the stock's decline in pre-market trading "seems to more than reflect the nasal naloxone opportunity," added Maris, who keeps an Outperform rating on Amphastar shares, which are down 15% in early trading after the opening bell to $15.62.
AVDL Avadel Pharmaceuticals
$9.45

-0.16 (-1.66%)

09/08/17
ROTH
09/08/17
NO CHANGE
Target $13.25
ROTH
Buy
Roth Capital 'cautiously optimistic' on Avadel's deal for Noctiva
Roth Capital analyst Scott Henry said he is "cautiously optimistic" on Avadel's (AVDL) deal to acquire U.S./Canadian rights for Noctiva, though he notes concerns, such as this drug needing an expensive, market-creating type of promotion and the fact that Allergan (AGN) walked away from a prior deal for Noctiva after its approval. He lowered his price target on Avadel to $13.25 from $15 to reflect lower cash post this acquisition, but keeps a Buy rating, citing his positive view on the sodium oxybate program.
09/07/17
LTCO
09/07/17
NO CHANGE
Target $30
LTCO
Buy
Avadel Pharmaceuticals price target raised to $30 from $27 at Ladenburg
02/24/17
RHCO
02/24/17
NO CHANGE
RHCO
Avadel Pharmaceuticals price target lowered to $13 from $17 at SunTrust
SunTrust analyst John Boris reduced his price target on Avadel (AVDL) after Endo (ENDP) launched an injectable drug that will compete, at a similar price point, with Avadel's Akovaz. The analyst adds that Avadel's Bloxiverz is also being challenged by Merck's (MRK) Bridion which is taking share in the neostigmine market. He lowered his estimates for Avadel below consensus levels but keeps a Buy rating on the name.
01/31/17
JEFF
01/31/17
NO CHANGE
Target $24
JEFF
Buy
Jefferies says new approvals now even more critical for Akorn
After Endo (ENDP) received approval for Corphedra, the second FDA approved formulation of ephedrine after Avadel Pharmaceuticals' (AVDL), Jefferies analyst David Steinberg says new product approvals are now even more critical to Akorn's (AKRX) 2017 outlook and share price. Both Endo and Avadel will compete with Akorn's largest product, Steinberg tells investors in a research note. His model assumes Akorn's ephedrine sales will decline to $80M in FY17 from $230M in FY16. The analyst keeps a Buy rating on Akorn, however, saying the shares look "very inexpensive" on "multiple valuation metrics."

TODAY'S FREE FLY STORIES

CVNA

Carvana

$14.07

0.08 (0.57%)

14:11
10/19/17
10/19
14:11
10/19/17
14:11
Periodicals
Carvana mentioned cautiously in a Seeking Alpha Article 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WIRE

Encore Wire

$46.10

0.05 (0.11%)

14:10
10/19/17
10/19
14:10
10/19/17
14:10
Initiation
Encore Wire initiated  »

Encore Wire reinitiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$91.57

-0.5104 (-0.55%)

, GE

General Electric

$23.60

0.48 (2.08%)

14:04
10/19/17
10/19
14:04
10/19/17
14:04
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$91.57

-0.5104 (-0.55%)

GE

General Electric

$23.60

0.48 (2.08%)

HON

Honeywell

$143.69

0.25 (0.17%)

SLB

Schlumberger

$64.75

-1.16 (-1.76%)

STI

SunTrust

$59.31

0.02 (0.03%)

SYF

Synchrony

$31.70

0.19 (0.60%)

CFG

Citizens Financial

$37.33

0.15 (0.40%)

KSU

Kansas City Southern

$102.34

-0.47 (-0.46%)

GNTX

Gentex

$20.46

0.12 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 02

    Nov

PYPL

PayPal

$67.26

0.59 (0.88%)

, ISRG

Intuitive Surgical

$354.37

-0.63 (-0.18%)

14:03
10/19/17
10/19
14:03
10/19/17
14:03
Earnings
Notable companies reporting after market close »

Notable companies…

PYPL

PayPal

$67.26

0.59 (0.88%)

ISRG

Intuitive Surgical

$354.37

-0.63 (-0.18%)

MXIM

Maxim Integrated

$49.85

-0.01 (-0.02%)

ETFC

E-Trade

$43.92

0.14 (0.32%)

PBCT

People's United

$18.24

0.15 (0.83%)

WAL

Western Alliance

$52.55

0.285 (0.55%)

ATHN

athenahealth

$120.78

0.78 (0.65%)

NCR

NCR Corp.

$37.06

-0.25 (-0.67%)

SKX

Skechers

$24.29

-0.8 (-3.19%)

ASB

Associated Banc-Corp

$24.48

0.075 (0.31%)

HA

Hawaiian Holdings

$40.15

0.35 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 07

    Nov

  • 09

    Nov

  • 29

    Nov

GIB

CGI Group

$53.62

0.04 (0.07%)

, RIO

Rio Tinto

$47.99

-0.031 (-0.06%)

14:01
10/19/17
10/19
14:01
10/19/17
14:01
Hot Stocks
CGI, Rio Tinto expand outsourcing partnership »

CGI (GIB) announced the…

GIB

CGI Group

$53.62

0.04 (0.07%)

RIO

Rio Tinto

$47.99

-0.031 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$61.39

-6.5961 (-9.70%)

14:00
10/19/17
10/19
14:00
10/19/17
14:00
Technical Analysis
Technical View: United Continental hits resistance, turns lower »

The shares have turned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

13:55
10/19/17
10/19
13:55
10/19/17
13:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

MET

MetLife

$52.90

0.095 (0.18%)

13:55
10/19/17
10/19
13:55
10/19/17
13:55
Conference/Events
MetLife to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 02

    Nov

KOS

Kosmos

$7.47

-0.035 (-0.47%)

13:50
10/19/17
10/19
13:50
10/19/17
13:50
Options
Call buying in Kosmos Energy »

Call buying in Kosmos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

13:45
10/19/17
10/19
13:45
10/19/17
13:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

GE

General Electric

$23.60

0.48 (2.08%)

, BHGE

Baker Hughes

$33.10

-0.705 (-2.09%)

13:40
10/19/17
10/19
13:40
10/19/17
13:40
Earnings
On The Fly: What to watch in General Electric earnings report »

General Electric Company…

GE

General Electric

$23.60

0.48 (2.08%)

BHGE

Baker Hughes

$33.10

-0.705 (-2.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 07

    Nov

ALLY

Ally Financial

$24.49

0.01 (0.04%)

13:40
10/19/17
10/19
13:40
10/19/17
13:40
Options
Ally Financial attracts call buying »

Ally Financial attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

13:35
10/19/17
10/19
13:35
10/19/17
13:35
General news
NY Fed accepted $102.61 B in daily reverse repos »

NY Fed accepted $102.61 B…

IMDZ

Immune Design

$6.55

-1.65 (-20.12%)

13:34
10/19/17
10/19
13:34
10/19/17
13:34
Hot Stocks
Immune Design lymphoma treatment granted EU orphan designation »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TGT

Target

$60.47

0.44 (0.73%)

13:34
10/19/17
10/19
13:34
10/19/17
13:34
Hot Stocks
Target to remodel more than 1,000 stores by end of 2020, expand Restock program »

Target unveiled the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UAL

United Continental

$60.70

-7.29 (-10.72%)

, DAL

Delta Air Lines

$52.17

-0.69 (-1.31%)

13:32
10/19/17
10/19
13:32
10/19/17
13:32
Hot Stocks
United drops as CEO acknowledges need to dig out of competitive 'hole' »

Shares of United…

UAL

United Continental

$60.70

-7.29 (-10.72%)

DAL

Delta Air Lines

$52.17

-0.69 (-1.31%)

AAL

American Airlines

$52.03

-0.04 (-0.08%)

JBLU

JetBlue

$20.07

-0.11 (-0.55%)

LUV

Southwest

$58.32

-0.51 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 01

    Nov

SBH

Sally Beauty

$16.55

-1.2038 (-6.78%)

, AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

13:24
10/19/17
10/19
13:24
10/19/17
13:24
Recommendations
Sally Beauty, Amazon.com, Ulta Beauty, Wal-Mart analyst commentary  »

DA Davidson speculates on…

SBH

Sally Beauty

$16.55

-1.2038 (-6.78%)

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

ULTA

Ulta Beauty

$198.37

-3.91 (-1.93%)

WMT

Wal-Mart

$86.39

0.17 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

  • 18

    Mar

NSC

Norfolk Southern

$129.33

-1.19 (-0.91%)

13:20
10/19/17
10/19
13:20
10/19/17
13:20
Options
Roundtrip in Norfolk Southern as spread trader banks large profits »

Roundtrip in Norfolk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

$NSD

NASDAQ Market Internals

13:17
10/19/17
10/19
13:17
10/19/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
10/19/17
10/19
13:16
10/19/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMC

Omnicom

$72.85

-2.6 (-3.45%)

13:15
10/19/17
10/19
13:15
10/19/17
13:15
Options
Omnicom put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
10/19/17
10/19
13:15
10/19/17
13:15
General news
Treasury's $5 B 30-year TIPS reopening garnered decent results »

Treasury's $5 B…

TSLA

Tesla

$359.65

3.9 (1.10%)

, VWDRY

Vestas

$28.88

-0.04 (-0.14%)

13:13
10/19/17
10/19
13:13
10/19/17
13:13
Hot Stocks
Tesla, Vestas partnering on $160M Australian renewable energy project »

Australia's…

TSLA

Tesla

$359.65

3.9 (1.10%)

VWDRY

Vestas

$28.88

-0.04 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

CVX

Chevron

$118.47

0.32 (0.27%)

13:12
10/19/17
10/19
13:12
10/19/17
13:12
Periodicals
Chevron temporarily halts activities in Iraqi Kurdistan, WSJ reports »

Chevron is temporarily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 09

    Nov

TSLA

Tesla

$359.65

3.9 (1.10%)

13:11
10/19/17
10/19
13:11
10/19/17
13:11
Periodicals
Tesla Model 3 has 'average reliability', Consumer Reports says »

With only a few hundred…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.